Search Results 1481-1490 of 17176 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

  2. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Participation eligibility · Documentation of HBsAg, hepatitis B surface antibody (HBsAb), hepatitis B core antibody (HBcAb), and hepatitis C virus (HCV) antibody ...

  3. Autoimmune encephalitis - Care at Mayo Clinic

    Mayo Clinic Laboratories was one of the first centers to offer an autoimmune encephalitis panel to check for antibodies and test for autoimmune encephalitis.

  4. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    Any single agent therapy, and any combination of cytotoxic, endocrine, biological targeted agents, and/or humanized antibodies, scheduled to be administered ...

  5. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

    ... antibody-based therapy) prior to registration. Patients who have undergone major surgery (e.g., in-patient procedures) ≤ 6 weeks prior to registration or ...

  6. Neurology - Clinical trials

    The purpose of this study is to evaluate the effectiveness of ONC201 administered following radiotherapy in participants with H3 K27M-mutant diffuse glioma. A ...

  7. Pneumococcal 20-valent conjugate vaccine (intramuscular route) - Mayo Clinic

    It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, such as ...

  8. Pediatrics Clinical Trials - Medical Professionals

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  9. DNA (cfDNA) Blood Test to Detect KRAS and Other Clinically Relevant Gene Mutations in Patients with Metastatic Colorectal Cancer

    ... antibody therapy) that are used in routine clinical practice. Currently, the only way to know if your tumor has one of these mutations is to take a tissue ...

  10. A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer - Mayo Clinic

    * Based on a test for antibodies to hepatitis B core antigens (anti-HBc) and ... * Patients who have a history of human immunodeficiency virus (HIV) antibody ...